Back to search

Article

Comparative effectiveness of preferred pharmacological treatment options for bipolar disorder among people with opioid use disorder in British Columbia and Ontario, Canada: protocol for parallel population-based target trial emulations

2026-04-03

Abstract excerpt

<h4>Introduction</h4> People with bipolar disorder (BD) and concurrent opioid use disorder (OUD) experience more severe clinical outcomes, including higher mortality, treatment complexity, and worse psychiatric symptoms, yet they are underserved due to a lack of tailored clinical guidelines and limited supporting research on competing treatment options. While pharmacological treatments for BD are well-established...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bcd6a0f0-3dc2-5964-ae7d-e27daa23010e
DOI
10.64898/2026.04.02.26350000
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparative effectiveness of preferred pharmacological treatment options for bipolar disorder among people with opioid use disorder in British Columbia and Ontario, Canada: protocol for parallel population-based target trial emulationsDOI 10.64898/2026.04.02.26350000
Antipsychotic Use in Bipolar Disorder: Clinical and Genomic Correlates– A Mayo Clinic Bipolar Disorder Biobank StudySemantic proximity
Pharmacotherapy exposure as a marker of disease complexity in bipolar disorder: Associations with clinical & genetic risk factors.Semantic proximity
Effectiveness of slow-release oral morphine versus other OAT regimens in key sub-populations: protocol for population-based target trial emulationSemantic proximity
Pharmacoepidemiology research: Drug therapy and drug safety in mental healthSemantic proximity
Use of Combinatorial Pharmacogenomic Guidance in Treating Psychiatric Disorders:financial impact on a health planSemantic proximity
Trends in Prescriptions of Lithium and Other Medications for Patients with Bipolar Disorder in Office-based Practices in the United States: 1996-2015Semantic proximity
Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm studySemantic proximity
Assessing demographic and clinical characteristics and healthcare resource utilization of patients with schizophrenia with inadequate response to antipsychotic treatmentSemantic proximity
Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: Treatment goals and approaches to functional recoverySemantic proximity
Diagnosis and management of bipolar disorder in primary care: a DSM-5 update.Semantic proximity
Comparative Mortality Risk of Aripiprazole, Olanzapine, Quetiapine and Risperidone in Alzheimer’s Disease: A Real□World Cohort Study with Treatment Effect Heterogeneity AnalysisSemantic proximity
Using epidemiological evidence to forecast population need for early treatment programmes in mental health: a generalisable Bayesian prediction methodology applied to and validated for first-episode psychosis in EnglandSemantic proximity
Select a neighboring publication to make it the new centre.